Share chart Adagio Therapeutics, Inc.
Extended chart
Simple chart
About Adagio Therapeutics, Inc.
Adagio Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и коммерциализацией растворов на основе антител для лечения инфекционных заболеваний в США. Его основным кандидатом в продукте является ADG20, нейтрализующее антитело, которое проходит фазу II / III клинических испытаний для лечения и профилактики коронавирусной болезни. Компания заключила соглашение о сотрудничестве с Adimab, LLC в области обнаружения и оптимизации патентованных антител. Adagio Therapeutics, Inc. more detailsIPO date | 2021-08-06 |
---|---|
ISIN | US00534A1025 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://adagiotx.com |
Цена ао | 3.48 |
Change price per day: | 0% (3.48) |
---|---|
Change price per week: | 0% (3.48) |
Change price per month: | 0% (3.48) |
Change price per 3 month: | 0% (3.48) |
Change price per half year: | 0% (3.48) |
Change price per year: | 0% (3.48) |
Change price per 3 year: | -12.12% (3.96) |
Change price per 5 year: | 0% (3.48) |
Change price per 10 year: | 0% (3.48) |
Change price per year to date: | 0% (3.48) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
![]() |
0.00206 | 89.82 | 1.47873 |
![]() |
0.00166 | 17.47 | 1.51433 |
ProShares Hedge Replication ETF | 0.00057 | 5.92 | 1.47892 |
![]() |
0.00012 | 24.86 | 1.43354 |
Vanguard Russell 2000 ETF | 0 | 17.16 | 1.48801 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Rebecca Dabora Ph.D. | Chief Technology & Manufacturing Officer | N/A | 1960 (65 years) |
Mr. David Hering M.B.A. | CEO & Director | 453.76k | 1976 (49 years) |
Ms. Laura Walker Ph.D. | Co-Founder & Chief Scientific Officer | N/A | 1985 (40 years) |
Ms. Jane Pritchett V. Henderson | CFO, Chief Bus. Officer & Treasurer | N/A | 1966 (59 years) |
Ms. Jill Andersen J.D. | Chief Legal Officer & Corp. Sec. | 580.12k | 1973 (52 years) |
Dr. Elham Hershberger Pharm.D. | Chief Devel. Officer | N/A | 1968 (57 years) |
Mr. Eric W. Kimble M.B.A. | Chief Commercial Officer | N/A | 1968 (57 years) |
Mr. Ed Campanaro | Sr. VP of Clinical Operations | N/A |
Address: United States, Waltham. MA, 303 Wyman Street - open in Google maps, open in Yandex maps
Website: https://adagiotx.com
Website: https://adagiotx.com